The advantages of cell therapy in the treatment of major diseases are increasingly evident! Pudong Innovative Pharmaceutical Enterprises Continuously Make Efforts!
AD |
In recent years, under the new background of building future industries in the country and Shanghai, Pudong has actively sought and laid out new tracks and directions. Currently, a number of innovative entities have been introduced and gathered in related fields such as targeted drugs, synthetic biology, AI+new drug research and development, new conjugated drugs, new protein degrading drugs, cell drugs, etc
In recent years, under the new background of building future industries in the country and Shanghai, Pudong has actively sought and laid out new tracks and directions. Currently, a number of innovative entities have been introduced and gathered in related fields such as targeted drugs, synthetic biology, AI+new drug research and development, new conjugated drugs, new protein degrading drugs, cell drugs, etc. Among them, the advantages of cell therapy, which is the first to "enter" the race track, in the treatment of major diseases have become increasingly apparent.
According to the latest data statistics, from January to August this year, Shanghai received a total of 133 clinical approvals for Class 1 innovative drugs, including 20 clinical trial approvals for cell and gene therapy. Pudong enterprises have demonstrated extraordinary strength.
Enabling cellular immunotherapy to benefit more patients
Cell and Gene Therapy (CGT) is an important "new track" in global technology and industry competition. On this emerging track, as of June 2023, Zhangjiang in Pudong accounts for 3/5 of the registered clinical trial projects for cell and gene therapy in Shanghai and 1/4 of the total in China, which have been approved nationwide. It has also taken the lead in launching China's first and second CAR-T cell drugs.
CAR-TEnabling cellular immunotherapy to benefit more patients
Aunt Qin achieved complete remission (CR) of the disease in the first month after infusion, which gave us great confidence in our treatment. Subsequent follow-up has been in a continuous state of remission. Currently, Aunt Qin has been following up at our lymphoma CAR-T clinic at Ruijin Hospital for more than five years. I am happy to tell her that you are already a healthy individual and can enjoy your old age to the fullest Yan Zixun, one of the attending doctors, introduced the situation of Aunt Qin's follow-up to the present day.
In the view of Professor Xu Pengpeng from the Hematology Department of Ruijin Hospital, the clinical development and marketing application of CAR-T in China has provided more clinical doctors with better anti-cancer weapons and also brought dawn of cure to patients.
CAR-T is an epoch-making treatment method. Previously, we were only limited to targeted therapy and chemotherapy, and more focused on the treatment of the tumor itself. CAR-T has changed this concept, "said Professor Xu Pengpeng." We are also exploring more possibilities, such as combination medication
The birth of CAR-T therapy marks another breakthrough step for humanity in overcoming tumors. The launch of Pudong CAR-T products has driven researchers to rush into the cell therapy track. As the concentration of innovation continues to increase, Pudong's unique GOI program, the Open Innovation Center for Large Enterprises, quickly infiltrates this field, including providing research and development assembly services for startups, including gene and cell therapy, AI drug screening, gene editing, and more.
The entire industry chain of Pudong CGT has taken shape in Zhangjiang
Since the beginning of this year, there have been good news in the Zhangjiang CGT industry, such as the official approval of the clinical trial application for the first and second global CAR-T cell therapy product targeting GPRC5D in China, and the first domestic universal NK cell therapy product targeting GPRC5D, which is about to officially enter the clinical phase I research phase.
In response to the challenges of strong technological innovation and large initial investment in gene therapy products, Shanghai has further improved its ecosystem of technological innovation and industrial development, promoting high-quality development of the biopharmaceutical industry.
As proposed in the newly released "Shanghai Action Plan for Promoting Gene Therapy Technology Innovation and Industrial Development (2023-2025)" (hereinafter referred to as the "Action Plan"), by 2025, Shanghai's gene therapy technology innovation strategy capability will be further enhanced, clinical research and transformation application capabilities will be further enhanced, the innovation system will be further improved, and the industrial ecology will be further optimized; Build more than 5 clinical medical research centers and demonstration research wards in gene therapy and related fields; Introduce and cultivate more than 15 leading and backbone enterprises in the gene therapy industry; 1-2 innovative products applied for listing.
This is a policy measure that systematically plans to promote gene therapy in the next three years, following the release of the Shanghai Action Plan for Promoting Cell Therapy Technology Innovation and Industrial Development (2022-2024) last year. The Action Plan includes 4 aspects, 12 major tasks, and 8 safeguard measures, aiming to enhance the innovative policy sources and clinical research transformation capabilities in the field of gene therapy, enhance the accessibility of gene therapy products, and enhance the level of industrial development.
It is worth noting that the Action Plan also points out to enhance the level of industrial development and strengthen the "1+1" industrial spatial layout. Among them, with Pudong Zhangjiang Cell and Gene Industry Park as the core, we will build an international gene industry landmark and create a cluster for gene therapy technology innovation and industrial development.
At present, Zhangjiang Cell and Gene Industry Park has gathered over 100 upstream and downstream related enterprises in the cell and gene industry chain. In November, the fourth Zhangjiang International Summit on Cell and Gene Therapy Industry is also about to be held. After three years, the summit has become one of the most influential event brands in the field of cell and gene therapy in China, gradually developing into a platform for cooperation and exchange across the entire industry chain of cell and gene therapy in China.
Pudong is planning to lay out an emerging track in the field of biopharmaceutical industry. In addition to the cell and gene therapy industries being key areas for layout and promotion, synthetic biology is also gradually growing in Pudong.
Source: Pudong Release
Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])
Mobile advertising space rental |
Tag: of The advantages cell therapy in the treatment major
Super Value Recommendation! The Three Most Worth Buying Mobile Phones within 1500 yuan
NextConquer international challenges! China has successfully independently developed
Guess you like
-
The 2025 Chinese New Year (Spring Festival) film box office has exploded, exceeding 3 billion RMB and setting a new record for presales!Detail
2025-01-29 11:55:06 1
-
Seres and Beihang University Join Hands to Build an Innovative Ecosystem, Deepening Industry-Academia-Research Collaboration and Promoting Technological TransformationDetail
2025-01-28 14:46:18 1
-
Douyin 2024 Platform Governance Report: Safeguarding Security, Building a Better CommunityDetail
2025-01-28 14:25:55 1
-
Chinese Scientists Develop a Lightweight Bionic Dexterous Hand with 19 Degrees of Freedom, Promising to Revolutionize Prosthetic and Robotics TechnologyDetail
2025-01-28 14:16:39 1
-
DeepSeek: A Chinese AI Startup's Meteoric Rise Shakes Up Global Tech and Sends US Stocks PlungingDetail
2025-01-28 14:13:23 1
-
WeChat's New Year's Red Envelope Feature Gets a Voice Message Upgrade for Warmer Wishes!Detail
2025-01-26 11:37:36 1
-
360 Digital Security Group and Zhibangyang Education Technology Join Forces to Build a New Ecosystem for Cybersecurity and AI Talent CultivationDetail
2025-01-24 15:09:51 1
-
Visionox Achieves Mass Production of AMOLED with Solid-State Laser Annealing (SLA) Technology, Ushering in a New Era for the Display IndustryDetail
2025-01-24 14:34:23 1
-
Seres at the Davos Forum: The Path to Globalizing New Energy Vehicles Through Cooperation in the Intelligent EraDetail
2025-01-23 13:28:12 1
-
Amazon to Close All French-Speaking Quebec Warehouses, Laying Off Nearly 2,000 EmployeesDetail
2025-01-23 10:51:23 1
-
The official launch of the 2025 Electric Bicycle Trade-in Policy: Upgraded Subsidy Standards, Procedures, and PromotionDetail
2025-01-23 10:48:52 1
-
Xbox Series X|S Officially Supports External Hard Drives Larger Than 16TB: Saying Goodbye to Storage WorriesDetail
2025-01-23 10:39:19 1
-
Leaders from the Beijing Chaoyang District CPPCC Visited Quantum Leap Group, Affirming its Contributions and Future Prospects in the Silver Hair EconomyDetail
2025-01-22 17:06:56 1
-
China's Car Imports Remain Sluggish in 2024: 12% Decline, Sharp Drop in New Energy VehiclesDetail
2025-01-22 11:37:25 1
-
China Railway Group Limited (CRGL) officially debunks "speed-up" ticket booking software: Not a shortcut, but a pathway to riskDetail
2025-01-22 11:36:09 1
-
Dago Bio Completes Over $20 Million A+ Round Funding to Accelerate Novel Molecular Glue Drug DevelopmentDetail
2025-01-22 11:34:05 11
-
Rapid Degradation of Global Lake Submerged Vegetation: Satellite Observations Reveal a Critical Period of Ecosystem ShiftDetail
2025-01-22 11:29:03 1
-
Star Ace Capital Group and Abu Dhabi Investment Office Partner to Build a Global Esports Industry BenchmarkDetail
2025-01-22 11:27:50 1
-
Hisense Television Leads the 100-Inch Large-Screen Market in 2024, Achieving an Unparalleled Industry LegacyDetail
2025-01-22 11:12:49 1
-
WeChat Launches "Gifts" Feature: Streamlining Gift-Giving and Powering Social Commerce GrowthDetail
2025-01-21 16:05:45 1